111 related articles for article (PubMed ID: 7648432)
1. The use of Zwittergent 3-14 in the purification of recombinant human interferon-beta Ser17 (Betaseron).
Russell-Harde D; Knauf M; Croze E
J Interferon Cytokine Res; 1995 Jan; 15(1):31-7. PubMed ID: 7648432
[TBL] [Abstract][Full Text] [Related]
2. [Isolation of expressed in E. coli human interferon beta1b (Ser17) by ion-exchange chromatography].
Romanov VP; Bezuglov VV; Bobrov MIu; Kostromina TI; Feofanov SA; Miroshnikov AI
Bioorg Khim; 2011; 37(3):327-33. PubMed ID: 21899047
[TBL] [Abstract][Full Text] [Related]
3. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
Upadhyay V; Singh A; Jha D; Singh A; Panda AK
Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
[TBL] [Abstract][Full Text] [Related]
4. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
Li M; Fan H; Liu J; Wang M; Wang L; Wang C
Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
[TBL] [Abstract][Full Text] [Related]
5. Betaseron.
Lin L
Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
[TBL] [Abstract][Full Text] [Related]
6. High throughput purification of recombinant human growth hormone using radial flow chromatography.
Singh SM; Sharma A; Panda AK
Protein Expr Purif; 2009 Nov; 68(1):54-9. PubMed ID: 19500673
[TBL] [Abstract][Full Text] [Related]
7. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
Petrov S; Nacheva G; Ivanov I
Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
[TBL] [Abstract][Full Text] [Related]
8. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.
Qi X; Sun Y; Xiong S
Microb Cell Fact; 2015 Feb; 14():24. PubMed ID: 25879903
[TBL] [Abstract][Full Text] [Related]
9. [Solubilization Specificities Interferon beta-1b from Inclusion Bodies].
Zhuravko AS; Kononova NV; Bobruskin AI
Bioorg Khim; 2015; 41(4):403-10. PubMed ID: 26615635
[TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
11. Improved Refolding of a Human IgG1 Fc (CH2-CH3) Scaffold from Its Inclusion Body in E. coli by Alkaline Solubilization.
Ishikawa S; Ishikawa H; Sato A
Biol Pharm Bull; 2022; 45(3):284-291. PubMed ID: 35228394
[TBL] [Abstract][Full Text] [Related]
12. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
[TBL] [Abstract][Full Text] [Related]
13. One-step extraction of functional recombinant aquaporin Z from inclusion bodies with optimal detergent.
Wang L; Zhou H; Li Z; Lim TK; Lim XS; Lin Q
Protein Expr Purif; 2015 Nov; 115():146-52. PubMed ID: 26278820
[TBL] [Abstract][Full Text] [Related]
14. Efficient renaturation of inclusion body proteins denatured by SDS.
He C; Ohnishi K
Biochem Biophys Res Commun; 2017 Sep; 490(4):1250-1253. PubMed ID: 28684315
[TBL] [Abstract][Full Text] [Related]
15. Efficient solubilization and purification of highly insoluble membrane proteins expressed as inclusion bodies using perfluorooctanoic acid.
Plucinsky SM; Root KT; Glover KJ
Protein Expr Purif; 2018 Mar; 143():34-37. PubMed ID: 29066155
[TBL] [Abstract][Full Text] [Related]
16. [Obtaining human recombinant (serine-17) beta-interferon by the method of oligonucleotide-directed mutagenesis and its expression in Escherichia coli].
Shekhter II; Beĭko VP; Bulenkov MT; Khodova OM; Kolevatykh MA; Izotova LS; Lebedeva MI; Rudenskiĭ AIu; Borukhov SI; Iurin VI
Antibiot Khimioter; 1991 Aug; 36(8):25-8. PubMed ID: 1755705
[TBL] [Abstract][Full Text] [Related]
17. Efficient solubilization, activation, and purification of recombinant Cry45Aa of Bacillus thuringiensis expressed as inclusion bodies in Escherichia coli.
Okumura S; Saitoh H; Wasano N; Katayama H; Higuchi K; Mizuki E; Inouye K
Protein Expr Purif; 2006 May; 47(1):144-51. PubMed ID: 16307894
[TBL] [Abstract][Full Text] [Related]
18. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and antiviral activity of recombinant human interferon-beta ser17 in African green monkeys.
Chiang J; Gloff CA; Soike KF; Williams G
J Interferon Res; 1993 Apr; 13(2):111-20. PubMed ID: 8509658
[TBL] [Abstract][Full Text] [Related]
20. Effect of post-solubilization conditions on the yield and efficiency of recombinant streptokinase purification at large-scale.
Beiroti A; Kavianpour A; Sepahi M; Arsalani F; Tavakoli Zaniani P; Jalalirad R
Protein Expr Purif; 2014 Sep; 101():127-32. PubMed ID: 24954109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
